Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SymBio collaborates with NCCS to explore use of brincidofovir in EBV-positive lymphoma

Sep. 3, 2021

Discovery and preclinical characterization of novel cyclic dinucleotide STING agonists

Sep. 3, 2021

AstraZeneca discloses adenosine receptor antagonists

Sep. 3, 2021

Stingray Therapeutics presents new ENPP1 inhibitors

Sep. 3, 2021

Bristol Myers Squibb presents PADI4 inhibitors

Sep. 3, 2021

Study identifies cell state as oncogene enabler

Sep. 3, 2021

JDQ-443: a mutant-selective, irreversible inhibitor of KRAS G12C with an unprecedented binding mode

Sep. 3, 2021

New Drosophila model casts light on cancer cachexia

Sep. 2, 2021

Innovent licenses rights to GenFleet's KRAS G12C inhibitor GFH-925

Sep. 2, 2021

TCMCB-07 attenuates muscle wasting and body weight loss in murine models of cancer cachexia

Sep. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.